A chewable multivitamin sold in 25 states has been recalled after federal inspectors discovered it contained lower-than-expected levels of vitamin D.
What To Know
The recall pertains to the Multivitamin with Fluoride Chewable Tablets, Grape Flavor, as noted in records from the FDA.
This product is manufactured by Winder Laboratories, LLC, located in Winder, Georgia.
Newsweek reached out to Winder Laboratories, LLC, and left a voicemail on Saturday morning requesting a statement.
Two versions of the multivitamin are affected by this recall. The first contains 0.25 mg of fluoride, packaged in bottles of 100 tablets, and is identified by NDC 75826‑169‑10 and UPC 3 15826 16910 2.
The second version contains 1.0 mg of fluoride, also available in 100-tablet bottles, with NDC 75826‑171‑10 and UPC 3 15826 17110 5.
This recall was initiated following an inspection by the U.S. Food and Drug Administration (FDA), which found that the product was subpotent for vitamin D, indicating it contained less of the vitamin than specified.
Vitamin D is essential for bone health as it aids in the body’s absorption of calcium and supports the immune system. Adequate vitamin D intake is crucial for overall health, particularly for skeletal and muscular well-being.
As a result of this finding, the manufacturer initiated a voluntary recall.
FDA records indicate that the recall involves 422 cases of the 0.25 mg product and 210 cases of the 1.0 mg product, with each case containing 12 bottles of 100 tablets.
Customers can identify affected products using the following lot information:
- Lot 1692303, serial number 138909557498, expiration date October 26, 2025
- Lot 1692304, serial number 131163901709, expiration date October 26, 2025
- Lot 1712301, serial number 163590222021, expiration date November 14, 2025
This recall is logged under recall number H‑0569‑2026 and is associated with FDA Event ID 97884.
The FDA has communicated initial recall notifications through letters.
Distribution records show that the affected product was shipped to 25 states and territories, which include Alabama, Arizona, California, Florida, Hawaii, Iowa, Illinois, Indiana, Massachusetts, Michigan, Missouri, Mississippi, North Carolina, New Jersey, New York, Oregon, Pennsylvania, Puerto Rico, Rhode Island, Tennessee, Texas, Utah, Washington, Wisconsin, and West Virginia.
The recall was initiated on October 27, 2025, with the FDA assigning its risk classification on March 13, 2026.
The recall is still in effect, and no end date has been announced.
What Is a Class III Recall?
The FDA classified this multivitamin recall as Class III, which is the agency’s lowest risk category.
A Class III recall is declared when the use of or exposure to a product is not likely to result in adverse health consequences, even though the product still fails to comply with FDA regulations.
In this case, the classification reflects the FDA’s evaluation that the subpotency of the product does not pose a significant health risk, but corrective action is still warranted.
